![](/img/cover-not-exists.png)
649 Update on the toxicity and response of a phase I trial of concurrent, daily gefitinib and radiation or chemo-radiation for patients with locally advanced squamous cell cancer of the head and neck (LASCCHN)
D. Raben, M. Kane, C. Chen, J. Song, L. Brualdi, A. Raben, K. Hu, S. Gollamudi, H. Quon, J. DanceyVolume:
2
Year:
2004
Language:
english
DOI:
10.1016/s1359-6349(04)80657-8
File:
PDF, 146 KB
english, 2004